Peter Maybarduk directs Public Citizen’s access to medicines group, which helps partners worldwide make medicine available and affordable for all. Maybarduk is an intellectual property expert and is available to speak about drug pricing, innovation policy, pandemic readiness and global health. Since 2010 the access group’s work has helped shape major medicine pricing legislation and executive action in the United States and abroad, reduce the price of key medicines, conserve health budgets, change the course of international trade negotiations, facilitate technology licensing, empower public agencies, discipline prescription drug corporations, and support a more robust and equitable global response to Covid-19.
Maybarduk has provided technical and strategic assistance to government agencies and health organizations in dozens of countries. He facilitates U.S. and global civil society alliances on access to medicines. Maybarduk’s commentary frequently appears in papers of record, including The New York Times and The Washington Post. He sits on the governance board of the Medicines Patent Pool, a United Nations-backed organization that negotiates licenses among drugmakers to expand global availability of affordable generics. Maybarduk studied technology law at the University of California at Berkeley and anthropology at The College of William and Mary in Virginia. He is an affiliate fellow with the Information Society Program at Yale Law School. Maybarduk founded International Professional Partnerships for Sierra Leone, a non-profit dedicated to supporting public sector development in one of the world’s least developed countries.
Read Public Citizen’s profile of Maybarduk.